JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2009) 202, 407-417       DOI: 10.1677/JOE-09-0109
© 2009 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
JOE-09-0109v1
JOE-09-0109v2
202/3/407    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Chen, Y.
Right arrow Articles by Pepling, M. E
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.
Right arrow Articles by Pepling, M. E

Estrogen can signal through multiple pathways to regulate oocyte cyst breakdown and primordial follicle assembly in the neonatal mouse ovary

Ying Chen, Kelsey Breen and Melissa E Pepling

Department of Biology, Syracuse University, 107 College Place, Syracuse, New York 13244, USA

(Correspondence should be addressed to M E Pepling; Email: mepeplin{at}syr.edu)

During mouse embryonic development, oocytes develop in germline cysts, formed by several rounds of cell division followed by incomplete cytokinesis. Shortly after birth, cysts break down and individual oocytes are enclosed by granulosa cells to form primordial follicles. At the same time, two-thirds of the oocytes die by apoptosis with only one-third surviving. We have previously shown that the steroid hormones, estradiol (E2), and progesterone as well as the phytoestrogen genistein can inhibit cyst breakdown and primordial follicle assembly. However, the mechanisms by which steroid hormones regulate oocyte cyst breakdown and selective oocyte survival are unknown. Here, we confirmed the expression of estrogen receptor (ER) mRNA and protein in neonatal mouse ovaries using reverse transcriptase-PCR, western blotting, and immunocytochemistry. We then used ER-specific agonists and antagonists to understand the mechanism of estrogen signaling. 4,4',4''-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol, an ER{alpha}-selective agonist, and 2,3-bis(4-hydroxyphenyl)-propionitrile, an ERβ-selective agonist, both inhibited cyst breakdown in organ culture, suggesting that E2 can signal through both the receptors to regulate cyst breakdown. ICI 182,780, an ER antagonist, completely blocked E2's action. 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride, an ER{alpha}-specific antagonist, fully blocked E2's effect on oocyte cyst breakdown and primordial follicle assembly and (R,R)-5,11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol, an ERβ-specific antagonist, partially blocked E2, further supporting the idea that both receptors are involved in estrogen signaling in neonatal oocyte development. E2 conjugated to BSA, which can only exert effects at the membrane, was able to inhibit cyst breakdown, implying that E2 could also function through a membrane-bound ER to regulate cyst breakdown.




This article has been cited by other articles:


Home page
ReproductionHome page
M. E Pepling, E. A Sundman, N. L Patterson, G. W Gephardt, L. Medico Jr, and K. I Wilson
Differences in oocyte development and estradiol sensitivity among mouse strains
Reproduction, February 1, 2010; 139(2): 349 - 357.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Society for Endocrinology.